No Tax Breaks for Drug Ads Act

This bill, S 4691 (No Tax Breaks for Drug Ads Act), removes a tax deduction for pharmaceutical companies that spend on direct-to-consumer advertising of prescription drugs. It directly affects drug manufacturers by eliminating the ability to deduct expenses for ads targeting the general public through TV, radio, print, online, or social media platforms. The key provision prohibits tax deductions for all such advertising costs starting after the bill's enactment date, without changing advertising rules or banning ads. This is a concrete tax policy change affecting pharmaceutical industry spending, not a regulatory measure.